Amphivena Therapeutics

OverviewSuggest Edit

Our mission is to eradicate blood cancers with a breakthrough therapy that harnesses the patient’s own immune system to destroy tumor cells and their precursors. Our aim is to restore the cellular balance needed for proper blood formation, function and circulation, restoring the flow of life to patients that face life threatening illnesses.
TypePrivate
Founded2012
HQSouth San Francisco, US
Websiteamphivena.com

Recent NewsAll News

Latest Updates

Employees (est.) (Jan 2020)13

Key People/Management at Amphivena Therapeutics

Christian Richard

Christian Richard

Board of Directors
Vinay Bhaskar

Vinay Bhaskar

Board of Directors
Florian Fischer

Florian Fischer

Board of Directors
Show more

Amphivena Therapeutics Office Locations

Amphivena Therapeutics has an office in South San Francisco
South San Francisco, US (HQ)
1828, One, Tower Pl
Show all (1)

Amphivena Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2012

Amphivena Therapeutics total Funding

$127.2 m

Amphivena Therapeutics latest funding size

$62 m

Time since last funding

4 months ago

Amphivena Therapeutics investors

Amphivena Therapeutics's latest funding round in September 2019 was reported to be $62 m. In total, Amphivena Therapeutics has raised $127.2 m
Show all financial metrics

Amphivena Therapeutics Online and Social Media Presence

Embed Graph

Amphivena Therapeutics News and Updates

Amphivena Therapeutics lands $62 mln Series C

South San Francisco-based Amphivena Therapeutics Inc, a developer of T cell engager therapeutics for cancer, has raised $62 million in Series C financing. NanoDimension and Qiming Venture Partners USA led the round.

Amphivena Therapeutics Frequently Asked Questions

  • When was Amphivena Therapeutics founded?

    Amphivena Therapeutics was founded in 2012.

  • Who are Amphivena Therapeutics key executives?

    Amphivena Therapeutics's key executives are Christian Richard, Vinay Bhaskar and Florian Fischer.

  • How many employees does Amphivena Therapeutics have?

    Amphivena Therapeutics has 13 employees.

  • Who are Amphivena Therapeutics competitors?

    Competitors of Amphivena Therapeutics include Foghorn Therapeutics, ApoGen Biotechnologies and Roivant Sciences.

  • Where is Amphivena Therapeutics headquarters?

    Amphivena Therapeutics headquarters is located at 1828, One, Tower Pl, South San Francisco.

  • Where are Amphivena Therapeutics offices?

    Amphivena Therapeutics has an office in South San Francisco.

  • How many offices does Amphivena Therapeutics have?

    Amphivena Therapeutics has 1 office.